Skip to main content
Top
Published in: Archives of Virology 8/2013

01-08-2013 | Brief Report

HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1

Authors: Dongdong Qin, Kai Li, Jialin Qu, Sen Wang, Chengcheng Zou, Yanrui Sheng, Ailong Huang, Hua Tang

Published in: Archives of Virology | Issue 8/2013

Login to get access

Abstract

The available evidence suggests that HBV proteins play an important role in the development of hepatocellular carcinoma (HCC). RhoC, a member of the Rho subfamily of the Ras superfamily of homologous genes, had been implicated in tumorigenesis and tumor progression. In a previous study, we demonstrated that HBx and HBs could up-regulate RhoC expression by enhancing its promoter activity. However, the specific mechanisms remain unclear. Here, we demonstrate that overexpression of Ets-1 results in upregulation of RhoC promoter activity and mRNA and protein levels. Expression of transcription factor Ets-1 was significantly higher in HepG2.2.15 cells than that in HepG2 cells. Meanwhile, infection of HepG2 cells with an HBV-adenovirus recombinant virus led to up-regulation of Ets-1. Of the four HBV proteins, HBx and HBs, could increase expression of Ets-1, which consequently contributed to the upregulation of RhoC. These findings might provide a novel insight into HBV-induced HCC metastasis.
Literature
1.
go back to reference Schutte K, Bornschein J, Malfertheiner P (2009) Hepatocellular carcinoma epidemiological trends and risk factors. Dig Dis 27(2):80–92CrossRefPubMed Schutte K, Bornschein J, Malfertheiner P (2009) Hepatocellular carcinoma epidemiological trends and risk factors. Dig Dis 27(2):80–92CrossRefPubMed
2.
go back to reference El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557–2576CrossRefPubMed El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557–2576CrossRefPubMed
3.
go back to reference Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58(4):273–277CrossRef Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58(4):273–277CrossRef
4.
go back to reference Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL (2004) Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer 90(12):2349–2355PubMed Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL (2004) Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer 90(12):2349–2355PubMed
5.
go back to reference Blum HE, Spangenberg HC (2007) Hepatocellular carcinoma: an update. Arch Iran Med 10(3):361–371PubMed Blum HE, Spangenberg HC (2007) Hepatocellular carcinoma: an update. Arch Iran Med 10(3):361–371PubMed
6.
go back to reference Ng SA, Lee C (2011) Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 46(8):974–990CrossRefPubMed Ng SA, Lee C (2011) Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 46(8):974–990CrossRefPubMed
7.
8.
go back to reference Van Aelst L, D’Souza-Schorey C (1997) Rho GTPases and signaling networks. Genes Dev 11(18):2295–2322CrossRefPubMed Van Aelst L, D’Souza-Schorey C (1997) Rho GTPases and signaling networks. Genes Dev 11(18):2295–2322CrossRefPubMed
9.
go back to reference Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406(6795):532–535CrossRefPubMed Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406(6795):532–535CrossRefPubMed
10.
go back to reference Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160(2):579–584CrossRefPubMed Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160(2):579–584CrossRefPubMed
11.
go back to reference Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y (2003) Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 9(14):5282–5286PubMed Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y (2003) Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 9(14):5282–5286PubMed
12.
go back to reference Wang W, Wu F, Fang F, Tao Y, Yang L (2008) Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res 14(21):6804–6812CrossRefPubMed Wang W, Wu F, Fang F, Tao Y, Yang L (2008) Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res 14(21):6804–6812CrossRefPubMed
13.
go back to reference Yao H, Dashner EJ, van Golen CM, van Golen KL (2006) RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 25(16):2285–2296CrossRefPubMed Yao H, Dashner EJ, van Golen CM, van Golen KL (2006) RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 25(16):2285–2296CrossRefPubMed
14.
go back to reference Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9(9):1950–1953PubMed Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9(9):1950–1953PubMed
15.
go back to reference Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM (2006) Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25(52):6959–6967CrossRefPubMed Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM (2006) Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25(52):6959–6967CrossRefPubMed
16.
go back to reference Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK, Kuphal S (2011) Ets-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer 130(12):2801–2811CrossRefPubMed Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK, Kuphal S (2011) Ets-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer 130(12):2801–2811CrossRefPubMed
17.
go back to reference Woods DB, Ghysdael J, Owen MJ (1992) Identification of nucleotide preferences in DNA sequences recognized specifically by c-Ets-1 protein. Nucleic Acids Res 20(4):699–704CrossRefPubMed Woods DB, Ghysdael J, Owen MJ (1992) Identification of nucleotide preferences in DNA sequences recognized specifically by c-Ets-1 protein. Nucleic Acids Res 20(4):699–704CrossRefPubMed
18.
go back to reference Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60(22):6519–6525PubMed Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60(22):6519–6525PubMed
19.
go back to reference Ito Y, Miyoshi E, Takeda T, Sakon M, Noda K, Tsujimoto M, Monden M, Taniguchi N, Matsuura N (2000) Expression and possible role of Ets-1 in hepatocellular carcinoma. Am J Clin Pathol 114(5):719–725CrossRefPubMed Ito Y, Miyoshi E, Takeda T, Sakon M, Noda K, Tsujimoto M, Monden M, Taniguchi N, Matsuura N (2000) Expression and possible role of Ets-1 in hepatocellular carcinoma. Am J Clin Pathol 114(5):719–725CrossRefPubMed
20.
21.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods 25(4):402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods 25(4):402–408CrossRefPubMed
22.
go back to reference Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369(9574):1742–1757CrossRefPubMed Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369(9574):1742–1757CrossRefPubMed
23.
go back to reference Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572CrossRefPubMed Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572CrossRefPubMed
24.
go back to reference Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S (1999) An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5(2):221–225CrossRefPubMed Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S (1999) An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5(2):221–225CrossRefPubMed
25.
go back to reference Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez-A C, Arroyo AG, Lopez-Cabrera M (2002) The hepatitis B virus × protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110(12):1831–1838PubMed Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez-A C, Arroyo AG, Lopez-Cabrera M (2002) The hepatitis B virus × protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110(12):1831–1838PubMed
26.
go back to reference Kato T, Fujita Y, Nakane K, Kojima T, Nozawa Y, Deguchi T, Ito M (2012) ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression. Biochem Biophys Res Commun 417(3):966–971CrossRefPubMed Kato T, Fujita Y, Nakane K, Kojima T, Nozawa Y, Deguchi T, Ito M (2012) ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression. Biochem Biophys Res Commun 417(3):966–971CrossRefPubMed
27.
go back to reference Li W, Miao X, Qi Z, Zeng W, Liang J, Liang Z (2010) Hepatitis B virus × protein up-regulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2. Virol J 7:45CrossRefPubMed Li W, Miao X, Qi Z, Zeng W, Liang J, Liang Z (2010) Hepatitis B virus × protein up-regulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2. Virol J 7:45CrossRefPubMed
28.
go back to reference Beasley RP, Lin CC, Hwang LY, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2(8256):1129–1133CrossRefPubMed Beasley RP, Lin CC, Hwang LY, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2(8256):1129–1133CrossRefPubMed
29.
go back to reference Murakami S (1999) Hepatitis B virus × protein:structure, function and biology. Intervirology 42(2–3):81–99CrossRefPubMed Murakami S (1999) Hepatitis B virus × protein:structure, function and biology. Intervirology 42(2–3):81–99CrossRefPubMed
30.
go back to reference Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R (1990) The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343(6257):457–461CrossRefPubMed Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R (1990) The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343(6257):457–461CrossRefPubMed
31.
go back to reference Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225(1):235–239CrossRefPubMed Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225(1):235–239CrossRefPubMed
32.
go back to reference Hildt E, Hofschneider PH (1998) The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res 154:315–329CrossRefPubMed Hildt E, Hofschneider PH (1998) The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res 154:315–329CrossRefPubMed
33.
go back to reference Benn J, Su F, Doria M, Schneider RJ (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70(8):4978–4985PubMed Benn J, Su F, Doria M, Schneider RJ (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70(8):4978–4985PubMed
34.
go back to reference Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR (1998) The human hepatitis B virus transactivator × gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Oncogene 16(18):2367–2380CrossRefPubMed Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR (1998) The human hepatitis B virus transactivator × gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Oncogene 16(18):2367–2380CrossRefPubMed
35.
go back to reference Ghosh S, Basu M, Roy SS (2012) ETS-1 regulates vascular endothelial growth factor-induced matrix metlloproteinase-9 and matrix metlloproteinase-13 expression in human ovarian carcinoma cell SKOV-3. J Biol Chem 287(49):29968–29978 Ghosh S, Basu M, Roy SS (2012) ETS-1 regulates vascular endothelial growth factor-induced matrix metlloproteinase-9 and matrix metlloproteinase-13 expression in human ovarian carcinoma cell SKOV-3. J Biol Chem 287(49):29968–29978
36.
go back to reference Gemma A, Esther P, Rosa A, Sonia E, Lina B (2012) Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization. Angiogenesis 15(4):657–669CrossRef Gemma A, Esther P, Rosa A, Sonia E, Lina B (2012) Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization. Angiogenesis 15(4):657–669CrossRef
38.
go back to reference Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M, Niino D, Sekine (2005) Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46(2):202–208CrossRefPubMed Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M, Niino D, Sekine (2005) Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46(2):202–208CrossRefPubMed
39.
go back to reference Chang XZ, Yu J, Zhang XH, Yin J, Wang T, Cao XC (2009) Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells. J Cancer Res Clin Oncology 135(4):581–590CrossRef Chang XZ, Yu J, Zhang XH, Yin J, Wang T, Cao XC (2009) Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells. J Cancer Res Clin Oncology 135(4):581–590CrossRef
40.
go back to reference Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O’Higgins N, Duffy MJ (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 91(7):1308–1315CrossRefPubMed Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O’Higgins N, Duffy MJ (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 91(7):1308–1315CrossRefPubMed
41.
go back to reference Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101(2):242–247CrossRefPubMed Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101(2):242–247CrossRefPubMed
42.
go back to reference Saeki H, Oda S, Kawaguchi H, Ohno S, Kuwano H, Maehara Y, Sugimachi K (2002) Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer 98(1):8–13CrossRefPubMed Saeki H, Oda S, Kawaguchi H, Ohno S, Kuwano H, Maehara Y, Sugimachi K (2002) Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer 98(1):8–13CrossRefPubMed
Metadata
Title
HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1
Authors
Dongdong Qin
Kai Li
Jialin Qu
Sen Wang
Chengcheng Zou
Yanrui Sheng
Ailong Huang
Hua Tang
Publication date
01-08-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1655-1

Other articles of this Issue 8/2013

Archives of Virology 8/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.